Stock Earnings

Question 1

What are Supernus Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Supernus Pharmaceuticals Inc has a total asset of $1,368, Net profit of $73

Question 2

What are the key financial ratios for SUPN?

Accepted Answer

Supernus Pharmaceuticals Inc's Current ratio is 4.12, has a Net margin is 11.04, sales per share of $11.81.

Question 3

How is Supernus Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Supernus Pharmaceuticals Inc largest revenue segment is Treatment of Central Nervous System Diseases, at a revenue of 661,817,000 in the most earnings release.For geography, United States is the primary market for Supernus Pharmaceuticals Inc, at a revenue of 661,817,000.

Question 4

Is Supernus Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Supernus Pharmaceuticals Inc has a net profit of $73

Question 5

Does Supernus Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Supernus Pharmaceuticals Inc has liability of 332

Question 6

How many outstanding shares for Supernus Pharmaceuticals Inc?

Accepted Answer

Supernus Pharmaceuticals Inc has a total outstanding shares of 55.74

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	681	661	607	667	579	520
Revenue Growth (YoY)	5%	9%	-9%	15%	11%	33%
Cost of Revenue	68	69	83	87	75	52
Gross Profit	612	592	523	580	504	467
Selling, General & Admin	373	321	336	377	282	192
Research & Development	107	108	91	74	90	76
Operating Expenses	571	502	508	533	396	285
Other Non Operating Income (Expenses)	--	0	0	-2	-3	-4
Pretax Income	-20	97	2	60	73	168
Income Tax Expense	-1	24	1	0	19	41
Net Income	-19	73	1	60	53	127
Net Income Growth	-132%	7,200%	-98%	13%	-57.99%	12%
Shares Outstanding (Diluted)	56.55	55.95	55.5	61.7	54.4	53.7
Shares Change (YoY)	1%	1%	-10%	13%	1%	0%
EPS (Diluted)	-0.34	1.32	0.02	0.98	0.98	2.36
EPS Growth	-132%	5,470%	-98%	0%	-57.99%	12%
Free Cash Flow	70	171	110	116	125	135
Free Cash Flow Per Share	1.23	3.05	1.98	1.88	2.29	2.51
Gross Margin	89.86%	89.56%	86.16%	86.95%	87.04%	89.8%
Operating Margin	6.02%	13.61%	2.3%	6.89%	18.65%	35%
Profit Margin	-2.79%	11.04%	0.16%	8.99%	9.15%	24.42%
Free Cash Flow Margin	10.27%	25.86%	18.12%	17.39%	21.58%	25.96%
EBITDA	126	170	98	131	140	200
EBITDA Margin	18.5%	25.71%	16.14%	19.64%	24.17%	38.46%
D&A For EBITDA	85	80	84	85	32	18
EBIT	41	90	14	46	108	182
EBIT Margin	6.02%	13.61%	2.3%	6.89%	18.65%	35%
Effective Tax Rate	5%	24.74%	50%	0%	26.02%	24.4%

Supernus Pharmaceuticals Inc (SUPN) Price

SUPN Stock Price Chart

SUPN Income

Follow-Up Questions